GLPwatch
Adlyxin vs Victoza
Drug comparison
Last updated 2026-05-28 15:46 UTCAdlyxin (lixisenatide) and Victoza (liraglutide) are both injectable medications for type 2 diabetes, but Victoza is also approved to reduce cardiovascular risk. Adlyxin is made by Sanofi, while Victoza is made by Novo Nordisk. Both are taken as daily shots under the skin, but they contain different active ingredients.
AI summary of the sources below.
| Adlyxin | Victoza | |
|---|---|---|
| Active ingredient | lixisenatide | liraglutide |
| Manufacturer | sanofi | novo-nordisk |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes, cardiovascular risk reduction |
| Label updated | — | 2023-02-06 |